SINOPHARM TECH (08156) has completed the capitalization of the loan.

Sinopharm Tech (08156) announced that all preconditions under the IAM Loan Capitalization Agreement and Quantum Loan Capitalization Agreement have been met and completed on November 15, 2024. After the completion of the IAM Loan Capitalization Agreement, 300 million IAM shares were issued to IAM at HK$0.1 per ordinary share, with the subscription price offsetting HK$30 million of IAM debt payment; 9.33 billion IAM convertible preference shares were issued to IAM at HK$0.1 per convertible preference share, with the subscription price offsetting approximately HK$93.2541 million of IAM debt balance payment. Upon completion of the IAM Loan Capitalization Agreement, all IAM debt has been fully repaid, and the company has been relieved of its obligations under the IAM debt. After the completion of the Quantum Loan Capitalization Agreement, 150 million Quantum shares were issued to Quantum at HK$0.1 per ordinary share, with the subscription price fully offsetting Quantum's debt. After the completion of the Quantum Loan Capitalization Agreement, all Quantum debt has been fully repaid, and the company has been relieved of its obligations under the Quantum debt. All the preconditions under the Creative Big Loan Capitalization Agreement have been met and completed on November 15, 2024. After the completion of the Creative Big Loan Capitalization Agreement, 548 million Creative Big convertible preference shares were issued to Creative Big at HK$0.1 per convertible preference share, with the subscription price fully offsetting the total Creative Big debt. After the completion of the Creative Big Loan Capitalization Agreement, all Creative Big debt has been fully repaid, and the company has been relieved of its obligations under the Creative Big debt.